Release date: 2024-08-05 16:57:57 Recommended: 122
Fidaxomicin, a potent macrolide antibiotic renowned for its ability to impede bacterial growth and reproduction by disrupting metabolic pathways within bacterial cells, holds promise for combating infectious ailments stemming from Clostridium difficile. As Fidaxomicin gains traction in the pharmaceutical sphere, the genuine price of this medication has emerged as a focal point of public curiosity.
There are different versions of Fidaxomicin in the drug market, and there are only two versions of the original drug on the market, Astellas and Astellas Japan, and the following are the prices of the two common versions:
The specifications for the Fidaxomicin Astellas variant consist of 200mg in each of the 20 capsules, with an estimated price of 16,675 yuan per package. Similarly, the Fidaxomicin Astellas version in Japan comprises 200mg within each of the 20 tablets, priced at approximately 8,500 yuan per unit. Despite being manufactured by Astellas Pharmaceutical, the pricing of the Fidaxomicin product may differ based on various factors including regional disparities, marketing strategies, and cost management, thus the aforementioned prices serve purely as a guideline.
Fidaxomicin is a pharmaceutical medication that necessitates a prescription, and patients are encouraged to seek medical advice and thoroughly comprehend the pertinent information pertaining to the drug including its indications, contraindications, and potential adverse effects prior to commencing usage, in order to mitigate unwarranted risks.
Fidaxomicin is primarily indicated for the management of Clostridium difficile-induced diarrhea. For alternative forms of infection, the efficacy of Fidaxomicin may be limited. Individuals are cautioned against self-administering Fidaxomicin for conditions not diagnosed by a doctor, and it is imperative to verify that the infection in question is indeed caused by Clostridium difficile before initiating treatment.
Fidaxomicin has the potential to interact with specific medications, leading to alterations in therapeutic outcomes. When treating with Fidaxomicin, patients should inform their doctor of other medications being used to avoid potential drug interactions.
Fidaxomicin may induce adverse effects, including nausea, vomiting, abdominal pain, and gastrointestinal bleeding. Patients are advised to closely monitor their physical state while taking the medication and promptly seek medical attention if they experience any discomfort or unusual reactions. Patients with allergies to Fidaxomicin should refrain from using this medication.
[Warm tips] When incorporating Fidaxomicin into their regimen, patients should adhere to their physician's recommendations and medication instructions. It is crucial not to alter the dosage or timing of the medication independently, as doing so could compromise the efficacy of the treatment. For any inquiries or discomfort, patients should promptly consult with a doctor.